In addition, analysis of a large cohort of breast cancer patients (more than 2000) revealed that high JMJD6 expression in human breast cancer with high Myc results in a lower overall survival presumably due to a higher metastatic burden (Fig. 10). Here, JMJD6 is linked to breast cancer.